U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285954) titled 'Mindfulness Walking Intervention to Enhance Resilience (iWalk)' on Oct. 16.
Brief Summary: This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).
The objectives are to evaluate:
1. Recruitment capability and retention rates,
2. Acceptability and adherence to the intervention,
3. Feasibility of assessment procedures, and
4. Preliminary effects on psychological, physiological, and behavioral outcomes.
Study Start Date:...